Hepatology · 2016 · 173 citations · 28 references
In liver injury, the exosome-mediated activation of TLR3 in HSCs exacerbates liver fibrosis by enhancing IL-17A production by γδ T cells, which might be associated with HSC stimulation by unknown self-TLR3 ligands from damaged hepatocytes. Therefore, TLR3 might be a novel therapeutic target for liver fibrosis. (Hepatology 2016;64:616-631).
28
Eva V. Acosta Rodríguez, Giorgio Napolitani, Antonio Lanzavecchia et al. · Nature Immunology · 2007 · 1.8K citations
mRNA Is an Endogenous Ligand for Toll-like Receptor 3
Katalin Karikó, Houping Ni, John Capodici et al. · Journal of Biological Chemistry · 2004 · 1K citations · Full text